» Articles » PMID: 31252639

Effect of Sulforaphane and 5-Aza-2'-Deoxycytidine on Melanoma Cell Growth

Overview
Specialty Pharmacology
Date 2019 Jun 30
PMID 31252639
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

UV exposure-induced oxidative stress is implicated as a driving mechanism for melanoma. Increased oxidative stress results in DNA damage and epigenetic dysregulation. Accordingly, we explored whether a low dose of the antioxidant sulforaphane (SFN) in combination with the epigenetic drug 5-aza-2'-deoxycytidine (DAC) could slow melanoma cell growth. SFN is a natural bioactivated product of the cruciferous family, while DAC is a DNA methyltransferase inhibitor. Melanoma cell growth characteristics, gene transcription profiles, and histone epigenetic modifications were measured after single and combination treatments with SFN and DAC. We detected melanoma cell growth inhibition and specific changes in gene expression profiles upon combinational treatments with SFN and DAC, while no significant alterations in histone epigenetic modifications were observed. Dysregulated gene transcription of a key immunoregulator cytokine-C-C motif ligand 5 (CCL-5)-was validated. These results indicate a potential combinatorial effect of a dietary antioxidant and an FDA-approved epigenetic drug in controlling melanoma cell growth.

Citing Articles

Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review.

Sailo B, Liu L, Chauhan S, Girisa S, Hegde M, Liang L Cancers (Basel). 2024; 16(2).

PMID: 38254735 PMC: 10814109. DOI: 10.3390/cancers16020244.


Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates.

El Omari N, Bakrim S, Bakha M, Lorenzo J, Rebezov M, Shariati M Nutrients. 2021; 13(11).

PMID: 34835969 PMC: 8621755. DOI: 10.3390/nu13113714.


Epigenetic Control of Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion.

Koss B, Shields B, Taylor E, Storey A, Byrum S, Gies A Cancer Res. 2020; 80(21):4707-4719.

PMID: 33004350 PMC: 7642172. DOI: 10.1158/0008-5472.CAN-20-0524.


The Impact of Natural Dietary Compounds and Food-Borne Mycotoxins on DNA Methylation and Cancer.

Ghazi T, Arumugam T, Foolchand A, Chuturgoon A Cells. 2020; 9(9).

PMID: 32878338 PMC: 7565866. DOI: 10.3390/cells9092004.


Natural Compounds as New Cancer Treatments.

Barrajon-Catalan E Medicines (Basel). 2019; 6(3).

PMID: 31340520 PMC: 6789864. DOI: 10.3390/medicines6030078.


References
1.
Sigalotti L, Covre A, Fratta E, Parisi G, Sonego P, Colizzi F . Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients. J Transl Med. 2012; 10:185. PMC: 3539917. DOI: 10.1186/1479-5876-10-185. View

2.
Cho S, Li G, Hu H, Jiang C, Kang K, Lee Y . Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells. Nutr Cancer. 2005; 52(2):213-24. DOI: 10.1207/s15327914nc5202_11. View

3.
Delijewski M, Wrzesniok D, Otreba M, Beberok A, Rok J, Buszman E . Nicotine impact on melanogenesis and antioxidant defense system in HEMn-DP melanocytes. Mol Cell Biochem. 2014; 395(1-2):109-16. PMC: 4131136. DOI: 10.1007/s11010-014-2116-1. View

4.
Drouin R, Therrien J . UVB-induced cyclobutane pyrimidine dimer frequency correlates with skin cancer mutational hotspots in p53. Photochem Photobiol. 1998; 66(5):719-26. DOI: 10.1111/j.1751-1097.1997.tb03213.x. View

5.
Tran T, Schulman J, Fisher D . UV and pigmentation: molecular mechanisms and social controversies. Pigment Cell Melanoma Res. 2008; 21(5):509-16. PMC: 2733367. DOI: 10.1111/j.1755-148X.2008.00498.x. View